Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

NCT02337062 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1147

Enrollment

INDUSTRY

Sponsor class

Conditions

PONV

Interventions

DRUG: APD421
DRUG: Placebo

Sponsor

Acacia Pharma Ltd